CYChenxi Yu

Chenxi Yu

*This is an algorithmically generated author record based on publicly available information.

Chenxi Yu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Corddl: An Efficient and Extensible Connector between Relational Databases and Data Lakes

    by Tao Zhang, Hao Liu, Chenxi Yu, Peng Wang

    In the era of big data, data lakes have been widely used. However, enterprise applications generally do not interact directly with data lakes, but with relational databases. Relational databases may become data silos because they can only store structured data. In this paper, we proposed Corddl, a connector between relational databases and data lakes. For ingesting data from a relational database into a data lake, first, Corddl uses configuration files and parameters to match the data source class and data source instance for the analysis engine. Then, Corddl uses the JDBC driver to realize the connection to the relational database, and do data conversion according to the data type configuration file. Finally, the ingested data is written into the data lake. There is a similar process for ingesting data from a data lake into a relational database. Experimental results show that Corddl has high efficiency and strong extensibility.

  • Open Access

    Treatment of osteonecrosis of the femoral head using prevascularized bone tissues constructed with human umbilical cord mesenchymal stem cells and human umbilical vein endothelial cells

    by Qiang Ren, Miaomiao Chai, Kaijia Chen, Guo Yuzhe, Zhou Yan, Cao Ning, Chenxi Yu

    Background: Studies have shown that osteonecrosis of the femoral head (ONFH)is related to bone marrow mesenchymal stem cell injury and microvascular injury. Early ONFH patients can choose core decompression and other treatments, but the clinical effect is poor. In recent years, tissue engineering technology based on mesenchymal stem cells is a new method to treat ONFH. In addition, whether the transplantation area is fully vascularized also affects whether the mesenchymal stem cells can play a repair role. In this study, we constructed prevascularized bone tissue based on human umbilical cord mesenchymal stem cells and human umbilical vein endothelial cells to evaluate the therapeutic effect of prevascularized bone tissue on ONFH. Objective: This paper is to investigate the effect of pre-vascularized bone tissue constructed by human umbilical cord mesenchymal stem cells and human umbilical vein endothelial cells on bone repair of necrotic femoral head, so as to provide theoretical basis for clinical treatment of necrotic femoral head. Methods: The rabbits were randomly divided into 5 groups, of which, 1 group was not given any intervention, while rabbit femoral head necrosis models were prepared for the other 4 groups by microwave heating method and they are respectively named mould-making group, static bone tissue group, dynamic bone tissue group and pre-vascularized bone tissue group according to the different substances injected into the femoral head. Various tests, including MRI, Micro-CT, HE staining and immunofluorescence staining, were performed after the animals were executed 8 weeks after treatment to assess the osteogenic ability of the implant and the repair effect of necrotic femoral head. Results: Various tests showed that the pre-vascularized bone tissue group had better ability to promote necrotic femoral head repair, and significant new bone formation and bone quality improvement occurred 8 weeks after surgery. The static bone tissue group and dynamic bone tissue group were similar in their ability to promote femoral head repair, with all the three groups outperforming the modeled group. Conclusions: The pre-vascularized bone tissue has a good effect on promoting the reconstruction of necrotic femoral head and shows superior osteogenesis, angiogenesis and bone repair effect. It is thus a good graft material for repairing necrotic femoral head and is of great value in the treatment of necrotic femoral head.

  • Open Access

    Transplantation of Human Umbilical Cord‐Derived Mesenchymal Stem Cells Improves Cartilage Repair in a Rabbit Model

    by Guihua Yang, Jiashen Shao, Jiachen Lin, Haixia Yang, Jing Jin, Chenxi Yu, Bo Shen, Xiaorui Hu, Huijie Si, Xiaoxin Li, et al.

    The aim of this study was to investigate the therapeutic efficacy and safety of transplanting human umbilical cord blood‐derived mesenchymal stem cells (hUCB‐MSCs) in the treatment of cartilage injury. First, the articular cartilage defect model in rabbits was constructed. Then, the identified hUCB‐MSCs and rabbit bone marrow stem cells (rBM‐MSCs) were transplanted into the bone defect, respectively, and the cartilage repair effect was observed by hematoxylin‐eosin (HE) staining and immunohistochemistry. Besides, the glycosaminoglycan (GAG) content and biomechanics of the restoration area were also evaluated. In our study, hUCB‐MSCs and rBM‐MSCs exhibited typical MSC characteristics, with positive expressions of CD73, CD105, and CD90 and negative for CD45, CD34, CD14, and HLA‐DR. After the transplantation of hUCB‐MSCs and rBM‐MSCs, the overall quality of cartilage tissue was significantly improved, and the recipients did not show significant side effects in general. However, the expression of matrix metalloproteinase‐13 (MMP‐13) in the de novo tissues of the hUCB‐MSCs and rBM‐MSCs groups was both increased, indicating that the novel tissues may have some potential osteoarthritic changes. In conclusion, our results suggest the therapeutic effect of hUCB‐MSCs transplantation in cartilage regeneration, providing a promising future in the clinical treatment of cartilage injury.


  • Open Access

    An Emerging Role for Circular RNAs in Osteoarthritis

    by Chen-Xi Yu, Shui Sun

    Yu CX, et al. Yonsei Med J. 2018 May;59(3):349-355. https://doi.org/10.3349/ymj.2018.59.3.349